REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

28/04/2017 14:30

RNS Number : 7325D
Hikma Pharmaceuticals Plc
28 April 2017
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Khalid Nabilsi
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Disposal of 19,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)
Price(s) and volume(s)
Price(s): 19.36
Volume(s): 19,500
d)
Aggregated information
Volume: 19,500
Price: 19.36
Total: 377,520.00
e)
Date of the transaction
28 April 2017
f)
Place of the transaction
London Stock Exchange (XLON)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBXGDSIBDBGRI